| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.3M | +15.7% | +40.2% |
| R&D Expense | $45.5M | +9.5% | +30.5% |
| SG&A Expense | $9.4M | +8.2% | +10.4% |
| Operating Income | -$49.1M | -26.7% | -44.8% |
| Pre-tax Income | -$48.2M | -26.0% | -51.0% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$48.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.9M | -66.0% | -68.6% |
| Short-term Investments | $171.3M | -8.2% | -42.6% |
| Accounts Receivable | $9.2M | +22.0% | +40.3% |
| Current Assets | $204.0M | -13.5% | -40.7% |
| Total Assets | $208.8M | -13.3% | -40.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$123.0M | — | — |
| Capital Expenditures | $79K | — | — |
| Investing Cash Flow | $83.2M | — | — |
| Financing Cash Flow | $2.5M | — | — |
| Free Cash Flow | -$123.0M | — | — |
| -26.0% |
| -56.5% |
| EPS (Basic) | -$0.21 | -23.5% | -50.0% |
| EPS (Diluted) | -$0.21 | -23.5% | -50.0% |
| $62.1M |
| +15.9% |
| +21.6% |
| Total Liabilities | $291.2M | +1.4% | -1.9% |
| Stockholders' Equity | -$82.3M | -78.6% | -252.1% |